What is the Price of Afrezza?
The price of Afrezza, an inhaled insulin, varies depending on factors such as dosage, quantity, and insurance coverage. A common prescription for Afrezza is for a 30-day supply of 4-unit cartridges and 8-unit cartridges [1].
How Does Insurance Affect Afrezza's Cost?
Insurance plans can significantly impact the out-of-pocket cost for Afrezza. The specific copay or coinsurance amount will depend on your individual insurance formulary and whether Afrezza is preferred or covered under your plan. Patients may find that their insurance covers a portion of the cost, reducing their personal expense [1].
Are There Patient Assistance Programs for Afrezza?
Financial assistance may be available for eligible patients to help manage the cost of Afrezza. These programs are often designed to lower copayments or provide other forms of financial support for individuals who meet certain criteria [1].
What is Afrezza and How Does it Work?
Afrezza is a rapid-acting inhaled insulin used to improve glycemic control in adults and children aged 4 years and older with diabetes mellitus [2]. It is a mealtime insulin that is inhaled through the lungs and absorbed quickly into the bloodstream to help manage blood sugar levels after eating [3].
When Does Afrezza's Patent Protection End?
Information regarding the specific patent expiration dates for Afrezza is available through specialized patent tracking services. For detailed insights into Afrezza's patent landscape, including expiration timelines and any associated litigation, DrugPatentWatch.com is a resource [4].